Channel:  Aligning Science Across Parkinson's (ASAP)

521 Articles

Inhibition of striatal dopamine release by the L-type calcium channel inhibitor isradipine co-varies with risk factors for Parkinson's
Brimblecombe, K. R., Conor-Robson, N., Bataille, C. J. R., Roberts, B. M., Gracie, C., te Water Naude, R., Karthik, G., Russell, A. J., Wade-Martins, R., Cragg, S. J.
10.1101/2020.07.03.186411 — Posted: 2023-06-09
escheR: Unified multi-dimensional visualizations with Gestalt principles
Guo, B., Huuki-Myers, L. A., Grant-Peters, M., Collado-Torres, L., Hicks, S. C.
10.1101/2023.03.18.533302 — Posted: 2023-06-08
Early striatal hyperexcitability in an in vitro human striatal microcircuit model carrying the Parkinson's GBA-N370S mutation
Do, Q. B., Ng, B., Marquez-Gomez, R., Beccano-Kelly, D., Ibarra-Aizpurua, N., Caiazza, M.-C., Lang, C., Baleriola, J., Bengoa-Vergniory, N., Wade-Martins, R.
10.1101/2023.03.01.530566 — Posted: 2023-06-07
α-synuclein promotes neuronal dysfunction and death by disrupting the binding of ankyrin to β-spectrin
Maor, G., Dubreuil, R. R., Feany, M. B.
10.1101/2023.06.02.543481 — Posted: 2023-06-05
Genetic meta-analysis of levodopa induced dyskinesia in Parkinson's disease
Martinez, A., Real, R., Lawton, M., Iwaki, H., Tan, M., Wu, L., Williams, N., Carroll, C., Grosset, D., Hardy, J., Ryten, M., Foltynie, T., Ben-Shlomo, Y., Shoai, M., Morris, H.
10.1101/2023.05.24.23290362 — Posted: 2023-05-30
Parkinson's Progression Markers Initiative: A Milestone-Based Strategy to Monitor PD Progression
Brumm, M. C., Siderowf, A., Simuni, T., Burghardt, E., Choi, S. H., Caspell-Garcia, C., Chahine, L., Mollenhauer, B., Foroud, T., Galasko, D., Merchant, K., Arnedo, V., Hutten, S. J., O'Grady, A. N., Poston, K. L., Tanner, C. M., Weintraub, D., Kieburtz, K., Marek, K., Coffey, C. S.
10.1101/2023.05.23.23290344 — Posted: 2023-05-24
Neuronal phase shifts differ for excitation vs. inhibition: a computer modeling study
Kelley, C., Antic, S. D., Carnevale, N. T., Kubie, J. L., Lytton, W. W.
10.1101/2023.03.20.533519 — Posted: 2023-05-23
Population fraction of Parkinson disease attributable to preventable risk factors
Payami, H., Cohen, G., Murchison, C. F., Sampson, T. R., Standaert, D. G., Wallen, Z. D.
10.1101/2023.05.19.23290231 — Posted: 2023-05-19
Spatial transcriptomics reveals molecular dysfunction associated with Lewy pathology
Goralski, T., Meyerdirk, L., Breton, L., Brasseur, L., Kurgat, K., DeWeerd, D., Turner, L., Becker, K., Adams, M., Newhouse, D., Henderson, M. X.
10.1101/2023.05.17.541144 — Posted: 2023-05-17
Defining the causes of sporadic Parkinson's disease in the global Parkinson's genetics program (GP2)
Towns, C., Richer, M., Jasaityte, S., Stafford, E., Joubert, J., Antar, T., Martinez-Carrasco, A., Makarious, M. B., Casey, B., Vitale, D., Levine, K., Leonard, H., Pantazis, C., Screven, L., Hernandez, D., Wegel, C. E., Solle, J., Nalls, M. A., Blauwendraat, C., Singleton, A. B., Tan, M. M. X., Iwaki, H., Morris, H. R., the Global Parkinson's Genetics Program (GP2)
10.1101/2022.11.25.22282764 — Posted: 2023-05-15

RSS  Channel RSS